AstraZeneca and Merck sign major deals with Chinese biotechs

AstraZeneca invests $2 billion in Akeso to develop a cancer treatment.

Published 6sem1 sourceNotable
Lire en français
≈ 16s

The fact

Merck signs a separate partnership, boosting the appeal of Chinese biotechs.

These deals occur despite ongoing concerns over U.S. restrictions.

Click the link to read an article on the topic:
Explore this topic
What if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.
Chine · © OpenStreetMap, OpenMapTiles, OpenFreeMapWorld map →
Follow topic →
Auto-synthesis from 1 media source · identified on September 29, 2026
← Back to home
Discover

Read more

All monde →